FindTrial
Sign In

Effect of Ashoka Twak Ksheerpak Taken Orally Followed by Ashoka Ghrita Uttarbasti in Women with Abnormal Uterine Bleeding.

A single arm clinical study to evaluate the combined effect of ashoka twaka ksheerpaka orally followed by ashoka ghruta uttarbasti in asrugdara [abnormal uterine bleeding (AUB)]. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105485
Enrollment
30
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R938- Abnormal findings on diagnostic imaging of other specified body structures

Interventions

None listed

Sponsors

Dr. Snehal Zole
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects with classical symptoms of Asrugdara(AUB). 2)Subjects are in the age group of 20-50 yrs. 3)Subjects who are married.

Exclusion criteria

Exclusion criteria: 1)Subject having STD. 2)Subject having PID. 3)Subjects having Coagulopathic Disorder. 4)Subjects having CA cervix.

Design outcomes

Primary

MeasureTime frame
To evaluate the combined effect of ashoka twaka ksheerpaka orally followed by ashoka ghruta uttarbasti in asrugdara [abnormal uterine bleeding (AUB)].Timepoint: To evaluate the combined effect of ashoka twaka ksheerpaka orally followed by ashoka ghruta uttarbasti in asrugdara [abnormal uterine bleeding (AUB)].—

Secondary

MeasureTime frame
1)To evaluate reduction in the endometrial thickness 2)To evaluate improvement in frequency, volume and duration of menstrual cycle. Timepoint: 90 days—

Countries

India

Contacts

Public ContactDr Snehal Zole

Seth Govindaji Raoji Ayurved Mahavidyaly Solapur

veena.jawale@sgrayurved.edu.in9028244410

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026